Literature DB >> 14644016

Clinical uses and misuses of dehydroepiandrosterone.

Emanuela Binello1, Catherine M Gordon.   

Abstract

Dehydroepiandrosterone is the most abundant adrenal androgen and also functions as a neurosteroid. Serum concentrations decline with age and can serve as a prognostic factor in both critical illnesses and breast cancer progression. Evidence is accruing in support of dehydroepiandrosterone supplementation in adrenal insufficiency, hypopituitarism, osteoporosis, systemic lupus erythematosus, depression and schizophrenia. Research is ongoing at both the basic and the clinical level to elucidate mechanisms of action and establish efficacy and safety, as well as to expand new areas of potential application for this multi-faceted hormone.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14644016     DOI: 10.1016/j.coph.2003.07.006

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  5 in total

Review 1.  Dehydroepiandrosterone (DHEA): hypes and hopes.

Authors:  Krzysztof Rutkowski; Paweł Sowa; Joanna Rutkowska-Talipska; Anna Kuryliszyn-Moskal; Ryszard Rutkowski
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

Review 2.  The Immunoregulatory Actions of DHEA in Tuberculosis, A Tool for Therapeutic Intervention?

Authors:  Bettina Bongiovanni; Ariana Díaz; Natalia Santucci; Luciano David D'Attilio; Oscar Bottasso; Rogelio Hernández Pando; María Luisa Bay
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-06       Impact factor: 6.055

3.  Vasodilator effects of dehydroepiandrosterone (DHEA) on fetal pulmonary circulation: An experimental study in pregnant sheep.

Authors:  Dyuti Sharma; Hélène Coridon; Estelle Aubry; Ali Houeijeh; Véronique Houfflin-Debarge; Rémi Besson; Philippe Deruelle; Laurent Storme
Journal:  PLoS One       Date:  2018-06-27       Impact factor: 3.240

4.  Randomised controlled trial of the effects of L-ornithine on stress markers and sleep quality in healthy workers.

Authors:  Mika Miyake; Takayoshi Kirisako; Takeshi Kokubo; Yutaka Miura; Koji Morishita; Hisayoshi Okamura; Akira Tsuda
Journal:  Nutr J       Date:  2014-06-03       Impact factor: 3.271

5.  Higher serum dehydroepiandrosterone sulfate protects against the onset of depression in the elderly: Findings from the English Longitudinal Study of Aging (ELSA).

Authors:  Luis H Souza-Teodoro; Cesar de Oliveira; Kate Walters; Livia A Carvalho
Journal:  Psychoneuroendocrinology       Date:  2015-11-12       Impact factor: 4.905

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.